Akero Therapeutics Inc’s filing revealed that its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.1 million on May 01 ’24. In the deal valued at $20.15 per share,5,000 shares were sold. As a result of this transaction, Young Jonathan now holds 258,306 shares worth roughly $4.96 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Young Jonathan sold 5,000 shares, generating $121,913 in total proceeds. Upon selling the shares at $24.38, the Chief Operating Officer now owns 263,306 shares.
Before that, Cheng Andrew sold 1,969 shares. Akero Therapeutics Inc shares valued at $55,782 were divested by the President and CEO at a price of $28.33 per share. As a result of the transaction, Cheng Andrew now holds 589,447 shares, worth roughly $11.33 million.
A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. UBS began covering AKRO with “Buy” recommendation on August 28, 2023. Morgan Stanley revised its rating on January 27, 2023. It rated AKRO as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of AKRO
On Tuesday, Akero Therapeutics Inc [NASDAQ:AKRO] saw its stock jump 0.16% to $19.22. Over the last five days, the stock has lost -1.44%. Akero Therapeutics Inc shares have fallen nearly -17.69% since the year began. Nevertheless, the stocks have fallen -58.87% over the past one year. While a 52-week high of $58.38 was reached on 03/04/24, a 52-week low of $11.25 was recorded on 02/06/24. SMA at 50 days reached $21.08, while 200 days put it at $25.65. A total of 0.95 million shares were traded, compared to the trading of 0.57 million shares in the previous session.
Levels Of Support And Resistance For AKRO Stock
The 24-hour chart illustrates a support level at 18.69, which if violated will result in even more drops to 18.15. On the upside, there is a resistance level at 19.79. A further resistance level may holdings at 20.35. The Relative Strength Index (RSI) on the 14-day chart is 44.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.28%. Stochastics %K at 31.00% indicates the stock is a holding.
